NCT04121000

Brief Summary

In this study our aim is to investigate the effects of continue erector spinae block on postoperative pain in patients who underwent thoracoscopic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable postoperative-pain

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 25, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 9, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

June 2, 2021

Status Verified

May 1, 2021

Enrollment Period

1.4 years

First QC Date

October 2, 2019

Last Update Submit

May 28, 2021

Conditions

Keywords

Erector Spinae Block,VATS

Outcome Measures

Primary Outcomes (1)

  • Perioperative and postoperative analgesic needs of patients

    Our primary outcome is to measure and identify the analgesic needs of the patients at the perioperative and postoperative period.In order to measure the analgesic needs Visual Analogue Scale will be used and patients' pain scores will be measured.

    Change in VAS scores at the first 48 hours

Secondary Outcomes (1)

  • side effect.

    1st, 4rd, 8th,12th, 24th, 36th and 48 th hours after the procedure.

Study Arms (2)

Erector Spinae Block for VATS Group

EXPERIMENTAL

40 patients who had VATS will receive erector spinae block for postoperative pain management. All patients will receive IV Midazolam (0.05mg/kg) premediacation. Standard monitorization of EKG, non- invasive blood pressure and pulsoximeter will be done and recorded in every 5 minutes. After sedation and standard monitorization, 20 minutes before the induction and in the prone positon the ESB procedure will be done. 10 % povidon- iodin will be used for sterilization and the USG probe will be covered with sterile sheath. The block will be done at the 8th thoracic vertebra line. The USG probe will be replaced 2-3 cm lateral to the spinous process in sagittal plane. When the erector spinae muscle is identified in the USG the needle will be guided caudally.0.5-1 ml local anesthetics will be given in order to confirm the needle is in the right place. After confirmation with 20 mL %0.25 bupivacaine the procedure will be performed.

Procedure: VIDEO ASSISTED THOTACOSOPIC SURGERY

Patient - Controlled Analgesia for VATS Group

EXPERIMENTAL

40 patients who had VATS will receive IV PCA for postoperative analgesia managemnet.

Procedure: VIDEO ASSISTED THOTACOSOPIC SURGERY

Interventions

VATS

Erector Spinae Block for VATS GroupPatient - Controlled Analgesia for VATS Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages between 20- 75
  • ASA (American Society of Anesthesiologists) Score I-III
  • Undergoing elective Video Assisted Thoracic Surgery

You may not qualify if:

  • ASA Score IV and higher
  • Patinets with neurological deficits
  • Paitents who have major vascular damage at the same side
  • Mentally retarded patients
  • Patients with alcohol or drug addiction
  • Patients who are allergic to local anesthetics
  • Pregnancy
  • Paitents with coagulopathy
  • Patients with skin infection at the side of the procedure
  • Patients with pneumothorax at the side of the procedure
  • Patient with a pacemaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zonguldak Bulent Ecevit University

Zonguldak, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • OZCAN PISKIN

    Bulent Ecevit University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study will be a two-arm parallel assignment. One group will receive erector spinae block and the other will receive PCA.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASSOCIATED PROFESSOR

Study Record Dates

First Submitted

October 2, 2019

First Posted

October 9, 2019

Study Start

June 25, 2019

Primary Completion

November 1, 2020

Study Completion

December 31, 2020

Last Updated

June 2, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations